Surgical Treatment of Chronic Amebic Colitis

M. Ozdogan,A. Baykal,B. Kavuklu,O. Aran

DOI: https://doi.org/10.1007/s00268-005-0169-8

IF: 3.282

2005-10-12

World Journal of Surgery

Abstract:

What problem does this paper attempt to address?

LncRNA and circRNA in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review

Qingmin Zeng,Chang-Hai Liu,Dongbo Wu,Wei Jiang,Nannan Zhang,Hong Tang

DOI: https://doi.org/10.3390/biom13030560

IF: 6.064

2023-03-21

Biomolecules

Abstract:Non-alcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disease worldwide. Early identification and prompt treatment are critical to optimize patient management and improve long-term prognosis. Long non-coding RNA (lncRNA) and circular RNA (circRNA) are recently emerging non-coding RNAs, and are highly stable and easily detected in the circulation, representing a promising non-invasive approach for predicting NAFLD. A literature search of the Pubmed, Embase, Web of Science, and Cochrane Library databases was performed and 36 eligible studies were retrieved, including 18 on NAFLD, 13 on nonalcoholic steatohepatitis (NASH), and 11 on fibrosis and/or cirrhosis. Dynamic changes in lncRNA expression were associated with the occurrence and progression of NAFLD, among which lncRNA NEAT1, MEG3, and MALAT1 exhibited great potential as biomarkers for NAFLD. Moreover, mitochondria-located circRNA SCAR can drive metaflammation and its inhibition might be a promising therapeutic target for NASH. In this systematic review, we highlight the great potential of lncRNA/circRNA for early diagnosis and progression assessment of NAFLD. To further verify their clinical value, large-cohort studies incorporating lncRNA and circRNA expression both in liver tissue and blood should be conducted. Additionally, detailed studies on the functional mechanisms of NEAT1, MEG3, and MALAT1 will be essential for elucidating their roles in diagnosing and treating NAFLD, NASH, and fibrosis.

biochemistry & molecular biology
The use of the microagglutination technique to determine the antibody status of healthy New Zealanders to Brucella abortus

K. Bettelheim,W. Maskill,R. Metcalfe,J. Pearce

DOI: https://doi.org/10.1017/S0022172400064627

1984-06-01

Journal of Hygiene

Abstract:Summary Sera from healthy blood donors from different parts of New Zealand, collected between 1977 and 1980, were analysed by the microagglutination technique for antibodies against Brucella abortus. Populations from both urban and rural areas were studied. The technique was shown to be capable of handling the 3351 sera studied and thus to be a useful screening test to assess the immune status of large populations. The results demonstrated some of the effects on the human population of the successful bovine brucellosis eradication programme.
An outcome audit at the epilepsy clinic: results from 1000 consecutive referrals

E. Tobias,A. Brodie,M. Brodie

DOI: https://doi.org/10.1016/S1059-1311(05)80161-X

IF: 3.414

1994-03-01

Seizure

Abstract:
Identification of potential feature genes in non-alcoholic fatty liver disease using bioinformatics analysis and machine learning strategies

Zhaohui Zhang,Shihao Wang,Zhengwen Zhu,Biao Nie

DOI: https://doi.org/10.1016/j.compbiomed.2023.106724

Abstract:The prevalence of non-alcoholic fatty liver disease (NAFLD) and NAFLD-associated hepatocellular carcinoma (HCC) has continuously increased in recent years. Machine learning is an effective method for screening the feature genes of a disease for prediction, prevention and personalized treatment. Here, we used the "limma" package and weighted gene co-expression network analysis (WGCNA) to screen 219 NAFLD-related genes and found that they were mainly enriched in inflammation-related pathways. Four feature genes (AXUD1, FOSB, GADD45B, and SOCS2) were screened by LASSO regression and support vector machine-recursive feature elimination (SVM-RFE) machine learning algorithms. Therefore, a clinical diagnostic model with an area under the curve (AUC) value of 0.994 was constructed, which was superior to other indicators of NAFLD. Significant correlations existed between feature genes expression and steatohepatitis histology or clinical variables. These findings were also validated in external datasets and a mouse model. Finally, we found that feature genes expression was significantly decreased in NAFLD-associated HCC and that SOCS2 may be a prognostic biomarker. Our findings may provide new insights into the diagnosis, prevention and treatment targets of NAFLD and NAFLD-associated HCC.
Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease

Changzhou Cai,Xin Song,Chaohui Yu

DOI: https://doi.org/10.3233/CBM-190169

2020-01-01

Cancer Biomarkers

Abstract:BACKGROUND: Hepatocellular carcinoma (HCC) is the leading cause of mortality worldwide. In recent years, the incidence of HCC induced by NAFLD is growing rapidly. OBJECTIVE: To screen for new pathogenic genes and related pathways both in NAFLD and HCC, and to explore the pathogenesis of progression from NAFLD to HCC. METHODS: Gene expression microarrays (GSE74656, GSE62232) were used for identifying differentially expressed genes (DEGs). Functional enrichment and pathway enrichment analyses indicated that these DEGs were related to cell cycle and extracellular exosome, which were closely related to NAFLD and HCC development. We then used the Search Tool for the Retrieval of Interacting Genes (STRING) to establish the protein-protein interaction (PPI) network and visualized them in Cytoscape. And the overall survival (OS) analysis and gene expression validation in TCGA of hub genes was performed. RESULTS: Seven hub genes, including CDK1, HSP90AA1, MAD2L1, PRKCD, ITGB3BP, CEP192, and RHOB were identified. Finally, we verified the expression level of ITGB3BP and CEP192 by quantitative real-time PCR in vitro. CONCLUSIONS: The present study implied possible DEGs, especially the new gene CEP192, in the progression of NAFLD developing to HCC. Further rigorous experiments are required to verify the above results.
Recent Progress of Proteomics in Nonalcoholic Fatty Liver Disease*

Ye Hua,Liu Wei,Yu Chao-Hui,Li You-Ming,Jiang Ying

DOI: https://doi.org/10.3724/sp.j.1206.2010.00566

2011-01-01

PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS

Abstract:Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease with an increasing morbidity. However, its pathogenesis is still elusive and its diagnosis and treatment need to be improved. The emergence of proteomics has pushed NAFLD research forward and twenty-one associated studies have been reported by now. Recent progress in proteomic techniques allows evaluation of molecular changes associated with disease, thereby permitting to identify novel biomarkers and therapeutic targets. Herein, the application of proteomics in the study of the diagnosis, pathogenesis and other related fields of NAFLD were comprehensively reviewed. Firstly, empirical knowledge about categories of subjects and samples, experimental methods and biomarker selection was summarized. Secondly, in addition to studies utilizing proteomics to explore roles of etiological factors, risk factors and important molecules in the pathogenesis of NAFLD, studies of NAFLD pathogenesis by the means of subcellular proteomics, modification-specific proteomics, and the integration of proteomics and transcriptomics were also shown. Thirdly, methods for analyzing differentially expressed proteins and implications of these results were highlighted. It's hoped that this review can help to promote the application of proteomics in exploring disease pathogenesis and discovering novel biomarkers and treatment targets.
Single-cell sequencing and multiple machine learning algorithms to identify key T-cell differentiation gene for progression of NAFLD cirrhosis to hepatocellular carcinoma

De-hua Wang,Li-hong Ye,Jing-yuan Ning,Xiao-kuan Zhang,Ting-ting Lv,Zi-jie Li,Zhi-yu Wang

DOI: https://doi.org/10.3389/fmolb.2024.1301099

IF: 6.113

2024-06-27

Frontiers in Molecular Biosciences

Abstract:Introduction: Hepatocellular carcinoma (HCC), which is closely associated with chronicinflammation, is the most common liver cancer and primarily involves dysregulated immune responses in the precancerous microenvironment. Currently, most studies have been limited to HCC incidence. However, the immunopathogenic mechanisms underlying precancerous lesions remain unknown. Methods: We obtained single-cell sequencing data (GSE136103) from two nonalcoholic fatty liver disease (NAFLD) cirrhosis samples and five healthy samples. Using pseudo-time analysis, we systematically identified five different T-cell differentiation states. Ten machine-learning algorithms were used in 81 combinations to integrate the frameworks and establish the best T-cell differentiation-related prognostic signature in a multi-cohort bulk transcriptome analysis. Results: LDHA was considered a core gene, and the results were validated using multiple external datasets. In addition, we validated LDHA expression using immunohistochemistry and flow cytometry. Conclusion: LDHA is a crucial marker gene in T cells for the progression of NAFLD cirrhosis to HCC.

biochemistry & molecular biology
MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease.

X Jin,Y-F Ye,S-H Chen,C-H Yu,J Liu,Y-M Li

DOI: https://doi.org/10.1016/j.dld.2008.08.008

IF: 5.165

2009-01-01

Digestive and Liver Disease

Abstract:To explore the unique microRNA expression pattern of nonalcoholic fatty liver disease in a rat model, and search for targets of certain dysregulated microRNAs.Microarray and stem-loop RT-PCR were utilized to detect dysregulated microRNAs in a rat model. Significance Analysis of Microarray, Prediction Analysis of Microarray and clustering analysis were implemented to calculate significantly aberrantly expressed microRNAs. TargetScan, miRanda and PicTar were jointly used to predict targets of microRNAs.Confirmed by Significance Analysis of Microarray and predicted by Prediction Analysis of Microarray, portfolios of 27 and 21 microRNAs were selected as an accurate molecular signature in distinguishing steatosis and steatohepatitis from normal rat liver. Besides, a panel of microRNA-target pairs that may be involved in lipid and glucose metabolism and inflammation process was delineated.This is by far the first report on the dysregulated microRNAs expression pattern in nonalcoholic fatty liver disease. The successful differentiation of steatosis and steatohepatitis from normal liver hints to the potential of using lists of dysregulated microRNAs for diagnosis, though many problems need to be solved. Besides, these data will guide further studies of the contribution of microRNAs to the pathogenesis of nonalcoholic fatty liver disease while disease-specific microRNAs might become potential targets for therapeutic intervention.
Identification of Shared and Unique Key Biomarkers of Alcohol Liver Cirrhosis and Non-Alcoholic Steatohepatitis Through Machine Learning Network-Based Algorithms

Morteza Hajihosseini,Fernanda Talarico,Caroline Zhao,Scott Campbell,Daniel Udenze,Nastaran Hajizadeh Bastani,Marawan Ahmed,Erfan Ghasemi,Lusine Tonoyan,Micheal Guirguis,Patrick Mayo,Corinne Campanella

DOI: https://doi.org/10.1101/2024.10.17.24315623

2024-10-18

Abstract:Introduction Liver fibrosis can progress to cirrhosis, liver failure, or hepatocellular carcinoma, which often requires transplantation and burdens healthcare systems around the world. Advances in single-cell RNA sequencing and machine learning have enhanced the understanding of immune responses in many liver diseases particularly alcohol liver cirrhosis (ALC) and non-alcoholic steatohepatitis (NASH). This study aims to identify key biomarkers involved in these conditions and assess their potential as non-invasive diagnostic tools. Methods Two gene expression profiles GSE136103 and GSE115469 were used to conduct differential gene expression (DEG) analysis. Using the results from DEG analysis, we then applied two machine learning network-based algorithms, master regulator analysis (MRA) and weighted key driver analysis (wKDA), to identify potential biomarker genes for NASH and ALC. Results A total of 1,435 and 5,074 DEGs were identified for ALC and NASH compared to healthy controls, including 1,077 shared DEGs between the two diseases. The MRA showed HLA-DPA1, HLA-DRB1, IFI44L, ISG15, and CD74 as the potential master regulators of ALC and HLA-DPB1, HLA-DQB1, HLA-DRB5, PFN1, and TMSB4X as the potential master regulators of NASH. In addition, wKDA analysis indicated CD300A, FCGR2A, RGS1, HLA-DMB, and C1QA as the key drivers of ALC and INPP5D, NCKAP1L, RAC2, PTPRC, and TYROBP as key drivers of NASH. Conclusion This study presented a comprehensive framework for analyzing single-cell RNA-seq data, demonstrating the potential of combining advanced network-based machine-learning techniques with conventional DEG analysis to uncover actionable prognostic markers for ALC and NASH with potential use as target biomarkers in drug development. Keywords: Liver, Cirrhosis, Steatohepatitis, Master Regulator, Key Driver
An novel effective and safe model for the diagnosis of nonalcoholic fatty liver disease in China: gene excavations, clinical validations, and mechanism elucidation

Jida Wang,Beitian Jia,Jing Miao,Dun Li,Yin Wang,Lu Han,Yin Yuan,Yuan Zhang,Yiyang Wang,Liying Guo,Jianwei Jia,Fang Zheng,Sizhen Lai,Kaijun Niu,Weidong Li,Yuhong Bian,Yaogang Wang

DOI: https://doi.org/10.1186/s12967-024-05315-3

IF: 8.44

2024-07-04

Journal of Translational Medicine

Abstract:Abstract Background Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases. NAFLD leads to liver fibrosis and hepatocellular carcinoma, and it also has systemic effects associated with metabolic diseases, cardiovascular diseases, chronic kidney disease, and malignant tumors. Therefore, it is important to diagnose NAFLD early to prevent these adverse effects. Methods The GSE89632 dataset was downloaded from the Gene Expression Omnibus database, and then the optimal genes were screened from the data cohort using lasso and Support Vector Machine Recursive Feature Elimination (SVM-RFE). The ROC values of the optimal genes for the diagnosis of NAFLD were calculated. The relationship between optimal genes and immune cells was determined using the DECONVOLUTION algorithm CIBERSORT. Finally, the specificity and sensitivity of the diagnostic genes were verified by detecting the expression of the diagnostic genes in blood samples from 320 NAFLD patients and liver samples from 12 mice. Results Through machine learning we identified FOSB , GPAT3, RGCC and RNF43 were the key diagnostic genes for NAFLD, and they were further demonstrated by a receiver operating characteristic curve analysis. We found that the combined diagnosis of the four genes identified NAFLD samples well from normal samples (AUC = 0.997). FOSB , GPAT3, RGCC and RNF43 were strongly associated with immune cell infiltration. We also experimentally examined the expression of these genes in NAFLD patients and NAFLD mice, and the results showed that these genes are highly specific and sensitive. Conclusions Data from both clinical and animal studies demonstrate the high sensitivity, specificity and safety of FOSB, GPAT3, RGCC and RNF43 for the diagnosis of NAFLD. The relationship between diagnostic key genes and immune cell infiltration may help to understand the development of NAFLD. The study was reviewed and approved by Ethics Committee of Tianjin Second People’s Hospital in 2021 (ChiCTR1900024415).

medicine, research & experimental
Intelligent Diagnosis of Non-alcoholic Fatty Liver Disease Based on Multi-modal Ultrasound Features

Gangqiao Xie,Yong-Sheng Xia,Shun-Ping Chen,Rui Wang,Xingyue Wei,Lijie Huang,Zhiqiang Li,Qiong He,Lai Wei,Ming-Hua Zheng,Jianwen Luo

DOI: https://doi.org/10.1109/IUS51837.2023.10307987

2023-01-01

Abstract:Non-alcoholic fatty liver disease (NAFLD) is a popular chronic disease worldwide, with a wide spectrum of conditions, ranging from fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH). Liver biopsy is the gold standard to diagnose NAFLD. However, it is an invasive procedure that is prone to sampling error and can lead to complications, which makes it an urgent need to develop non-invasive tests. Ultrasound (US) is an inexpensive, nonionizing-radiative, and real-time imaging modality that is used widely in practice. Ballooning and inflammation are very important for evaluating NASH resolution. In this study, we stage ballooning and inflammation based on multi-modal US features extracted from radiofrequency (RF) data, B-mode images, shear wave elastography (SWE) images, and baseline data. The results demonstrated that the multi-modal quantitative US features can stage ballooning and inflammation with moderate or good performance, indicating that the multi-modal US features may be a promising way to guide liver biopsy and NASH resolution.
Potential diagnostic markers shared between non-alcoholic fatty liver disease and atherosclerosis determined by machine learning and bioinformatic analysis

Lihong Wang,Wenhui He,Xilin Wang,Jianrong Wang,Xiaojuan Wei,Dongzhi Wu,Yundan Wu

DOI: https://doi.org/10.3389/fmed.2024.1322102

IF: 3.9

2024-03-28

Frontiers in Medicine

Abstract:Background Evidence indicates that chronic non-alcoholic fatty liver disease (NAFLD) can increase the risk of atherosclerosis (AS), but the underlying mechanism remains unclear. Objective This study is intended for confirming key genes shared between NAFLD and AS, and their clinical diagnostic value to establish a foundation for searching novel therapeutic targets. Methods We downloaded the Gene Expression Omnibus (GEO) datasets, GSE48452 and GSE89632 for NAFLD and GSE100927, GSE40231 and GSE28829 for AS. The progression of NAFLD co-expression gene modules were recognized via weighted gene co-expression network analysis (WGCNA). We screened for differentially expressed genes (DEGs) associated with AS and identified common genes associated with NAFLD and AS using Venn diagrams. We investigated the most significant core genes between NAFLD and AS using machine learning algorithms. We then constructed a diagnostic model by creating a nomogram and evaluating its performance using ROC curves. Furthermore, the CIBERSORT algorithm was utilized to explore the immune cell infiltration between the two diseases, and evaluate the relationship between diagnostic genes and immune cells. Results The WGCNA findings associated 1,129 key genes with NAFLD, and the difference analysis results identified 625 DEGs in AS, and 47 genes that were common to both diseases. We screened the core RPS6KA1 and SERPINA3 genes associated with NAFLD and AS using three machine learning algorithms. A nomogram and ROC curves demonstrated that these genes had great clinical meaning. We found differential expression of RPS6KA1 in patients with steatosis and NASH, and of SERPINA3 only in those with NASH compared with normal individuals. Immune infiltration findings revealed that macrophage and mast cell infiltration play important roles in the development of NAFLD and AS. Notably, SERPINA3 correlated negatively, whereas RPS6KA1 correlated positively with macrophages and mast cells. Conclusion We identified RPS6KA1 and SERPINA3 as potential diagnostic markers for NAFLD and AS. The most promising marker for a diagnosis of NAFLD and AS might be RPS6KA1 , whereas SERPINA3 is the most closely related gene for NASH and AS. We believe that further exploration of these core genes will reveal the etiology and a pathological relationship between NAFLD and AS.

medicine, general & internal
1567-P: Integrating Bioinformatics and Machine Learning to Identify Lactylation-Related Diagnostic Biomarkers and Characterize Immune Cell Infiltration in Nonalcoholic Fatty Liver Disease

JUNYI ZHANG,XUEYAN WU

DOI: https://doi.org/10.2337/db24-1567-p

IF: 7.7

2024-06-14

Diabetes

Abstract:Background: This study sought to explore potential lactylation-related targets for non-alcoholic fatty liver disease (NAFLD) and examine the role of immune cell infiltration in the disease's progression. Methods: Gene expression datasets were sourced from the Gene Expression Omnibus collection, and genomic enrichment analysis was conducted utilizing differentially expressed genes (DEGs). Overlapping lactylation and NAFLD DEGs were determined using a Venn diagram, and a protein-protein interaction (PPI) network was developed. To ascertain immune patterns, the ConsensusClusterPlus package in R was employed. Key genes were identified using three machine-learning algorithms: random forest, support vector machine-recursive feature elimination, and least absolute shrinkage and selection operator. The infiltration of immune cells was assessed by the GSVA package. The upstream transcriptional factors (TFs) and microRNAs (miRNAs) were predicted using the Regnetwork database and NetworkAnalyst. Results: The intersection of key genes and DEGs yielded 34 genes associated with lactylation and NAFLD, comprising 22 upregulated and 12 downregulated genes. Eight genes, namely FABP5, SIRT1, TERF2, ADNP, BTF3, CDC5L, DDX17, and MNDA, were identified as diagnostic indicators with relatively high diagnostic specificity for NAFLD. The interaction among key genes were shown by PPI network. A spectrum of immune cells was found to potentially contribute to NAFLD development. The association between key genes and immune infiltration were revealed by the correlation analysis. Also, we predicted the upstream TFs and miRNAs of hub genes. Conclusions: Our research identified 8 key genes related to lactylation and analyzed the immune cell infiltration characteristics in NAFLD patients, thereby offering additional insights into the potential mechanisms influencing NAFLD prognosis. Disclosure J. Zhang: None. X. Wu: None.

endocrinology & metabolism
Identification of key target genes and pathway analysis in nonalcoholic fatty liver disease via integrated bioinformatics analysis

X. Chen,L. Zhang,Y. Wang,R. Li,M. Yang,L. Gao

DOI: https://doi.org/10.2478/bjmg-2022-0006

2022-06-01

Balkan Journal of Medical Genetics

Abstract:Abstract Purpose This study aimed at exploring the mechanisms underlying nonalcoholic fatty liver disease (NAFLD) and developing new diagnostic biomarkers for nonalcoholic steatohepatitis (NASH). Methods The microarray dataset GES83452 was downloaded from the NCBI-GEO database, and the differentially expressed RNAs (DERs) were screened between the NAFLD and non-NAFLD samples of the baseline and 1-year follow-up time point group based on the Limma package. Results A total of 561 DERs (268 downregulated and 293 upregulated) were screened in the baseline time point group, and 1163 DERs (522 downregulated and 641 upregulated) were screened in the 1-year follow-up time point group. A total of 74 lncRNA–miRNA pairs and 523 miRNA–mRNA pairs were obtained in order to construct a lncRNA–miRNA–mRNA regulatory network. Subsequently, functional enrichment analysis revealed 28 GO and 9 KEGG pathways in the ceRNA regulatory network. LEPR and CXCL10 are involved in the Cytokine–cytokine receptor interaction ( P = 1.86E-02), and the FOXO1 is involved in both the insulin signaling pathway ( P = 1.79E-02) and the pathways in cancer ( P = 2.87E-02). Conclusion LEPR , CXCL10 , and FOXO1 were the characteristic target genes for NAFLD.

genetics & heredity
Six-gene prognostic signature for non-alcoholic fatty liver disease susceptibility using machine learning

Xiang Zhang,Chunzi Zhou,Jingwen Hu,Yueping Ding,Shiqi Chen,Xu Wang,Lei Xu,Zhijun Gou,Shuqiao Zhang,Weiqun Shi

DOI: https://doi.org/10.1097/MD.0000000000038076

2024-05-10

Abstract:Background: nonalcoholic fatty liver disease (NAFLD) is a common liver disease affecting the global population and its impact on human health will continue to increase. Genetic susceptibility is an important factor influencing its onset and progression, and there is a lack of reliable methods to predict the susceptibility of normal populations to NAFLD using appropriate genes. Methods: RNA sequencing data relating to nonalcoholic fatty liver disease was analyzed using the "limma" package within the R software. Differentially expressed genes were obtained through preliminary intersection screening. Core genes were analyzed and obtained by establishing and comparing 4 machine learning models, then a prediction model for NAFLD was constructed. The effectiveness of the model was then evaluated, and its applicability and reliability verified. Finally, we conducted further gene correlation analysis, analysis of biological function and analysis of immune infiltration. Results: By comparing 4 machine learning algorithms, we identified SVM as the optimal model, with the first 6 genes (CD247, S100A9, CSF3R, DIP2C, OXCT 2 and PRAMEF16) as predictive genes. The nomogram was found to have good reliability and effectiveness. Six genes' receiver operating characteristic curves (ROC) suggest an essential role in NAFLD pathogenesis, and they exhibit a high predictive value. Further analysis of immunology demonstrated that these 6 genes were closely connected to various immune cells and pathways. Conclusion: This study has successfully constructed an advanced and reliable prediction model based on 6 diagnostic gene markers to predict the susceptibility of normal populations to NAFLD, while also providing insights for potential targeted therapies.
Gold neuropathy

J. Walsh

DOI: https://doi.org/10.1212/WNL.20.5.455

IF: 9.9

1970-05-01

Neurology

Abstract:GOLD SALTS are in common use in the management of rheumatoid arthritis. Toxic reactions occur frequently b u t usually are mild and transient, commonly involving the skin, liver, or kidneys1 Involvement of the peripheral nervous system is a rare complication of gold therapy.283 There have been no reports describing the pathological changes that occur in the peripheral nervous system, and since a symmetrical polyneuropathy may complicate rheumatoid arthritis? interpretation of pathological changes would be difficult. For this reason, the results of electrophysiological and pathological studies are reported i n a patient with osteoarthritis who developed an acute peripheral neuropathy following the use of gold injections.
Machine learning approaches for early detection of non-alcoholic steatohepatitis based on clinical and blood parameters

Amir Reza Naderi Yaghouti,Hamed Zamanian,Ahmad Shalbaf

DOI: https://doi.org/10.1038/s41598-024-51741-0

IF: 4.6

2024-01-30

Scientific Reports

Abstract:This study aims to develop a machine learning approach leveraging clinical data and blood parameters to predict non-alcoholic steatohepatitis (NASH) based on the NAFLD Activity Score (NAS). Using a dataset of 181 patients, we performed preprocessing including normalization and categorical encoding. To identify predictive features, we applied sequential forward selection (SFS), chi-square, analysis of variance (ANOVA), and mutual information (MI). The selected features were used to train machine learning classifiers including SVM, random forest, AdaBoost, LightGBM, and XGBoost. Hyperparameter tuning was done for each classifier using randomized search. Model evaluation was performed using leave-one-out cross-validation over 100 repetitions. Among the classifiers, random forest, combined with SFS feature selection and 10 features, obtained the best performance: Accuracy: 81.32% ± 6.43%, Sensitivity: 86.04% ± 6.21%, Specificity: 70.49% ± 8.12% Precision: 81.59% ± 6.23%, and F1-score: 83.75% ± 6.23% percent. Our findings highlight the promise of machine learning in enhancing early diagnosis of NASH and provide a compelling alternative to conventional diagnostic techniques. Consequently, this study highlights the promise of machine learning techniques in enhancing early and non-invasive diagnosis of NASH based on readily available clinical and blood data. Our findings provide the basis for developing scalable approaches that can improve screening and monitoring of NASH progression.

multidisciplinary sciences
Identification of autophagy-related signatures in nonalcoholic fatty liver disease and correlation with non-parenchymal cells of the liver

Kaiwei Chen,Ling Wei,Shengnan Yu,Ningning He,Fengjuan Zhang

DOI: https://doi.org/10.1039/d4mo00060a

2024-08-12

Abstract:Non-alcoholic fatty liver disease (NAFLD) is a chronic hepatic disease. The incidence and prevalence of NAFLD have increased greatly in recent years, and there is still a lack of effective drugs. Autophagy plays an important role in promoting liver metabolism and maintaining liver homeostasis, and defects in autophagy levels are considered to be related to the development of NAFLD. However, the molecular mechanisms of autophagy in NAFLD still remain unknown. In this study, we identified 6 autophagy-associated hub genes using gene expression profiles obtained from the GSE48452 and GSE89632 datasets. Biomarkers were screened according to gene significance (GS) and module membership (MM) using weighted gene co-expression network analysis (WGCNA), and the immune infiltration landscape of the liver in NAFLD patients was explored using the CIBERSORT algorithm. Subsequently, we analyzed the relationship between liver non-parenchymal cells and autophagy-related hub genes using scRNA-seq data (GSE129516). Finally, we separated the NAFLD patients into two groups based on 6 hub genes by consensus clustering and screened 10 potential autophagy-related small molecules based on the cMAP database.
Identification of neutrophil extracellular trap-related biomarkers in non-alcoholic fatty liver disease through machine learning and single-cell analysis

Zhihao Fang,Changxu Liu,Xiaoxiao Yu,Kai Yang,Tianqi Yu,Yanchao Ji,Chang Liu

DOI: https://doi.org/10.1038/s41598-024-72151-2

IF: 4.6

2024-09-11

Scientific Reports

Abstract:Non-alcoholic Fatty Liver Disease (NAFLD), noted for its widespread prevalence among adults, has become the leading chronic liver condition globally. Simultaneously, the annual disease burden, particularly liver cirrhosis caused by NAFLD, has increased significantly. Neutrophil Extracellular Traps (NETs) play a crucial role in the progression of this disease and are key to the pathogenesis of NAFLD. However, research into the specific roles of NETs-related genes in NAFLD is still a field requiring thorough investigation. Utilizing techniques like AddModuleScore, ssGSEA, and WGCNA, our team conducted gene screening to identify the genes linked to NETs in both single-cell and bulk transcriptomics. Using algorithms including Random Forest, Support Vector Machine, Least Absolute Shrinkage, and Selection Operator, we identified ZFP36L2 and PHLDA1 as key hub genes. The pivotal role of these genes in NAFLD diagnosis was confirmed using the training dataset GSE164760. This study identified 116 genes linked to NETs across single-cell and bulk transcriptomic analyses. These genes demonstrated enrichment in immune and metabolic pathways. Additionally, two NETs-related hub genes, PHLDA1 and ZFP36L2, were selected through machine learning for integration into a prognostic model. These hub genes play roles in inflammatory and metabolic processes. scRNA-seq results showed variations in cellular communication among cells with different expression patterns of these key genes. In conclusion, this study explored the molecular characteristics of NETs-associated genes in NAFLD. It identified two potential biomarkers and analyzed their roles in the hepatic microenvironment. These discoveries could aid in NAFLD diagnosis and management, with the ultimate goal of enhancing patient outcomes.

multidisciplinary sciences
Combined with multiplex and network analysis to reveal the key genes and mechanisms of nonalcoholic fatty liver disease

Zhao Yang,Xuebing Han,Keyu Wang,Jun Fang,Zheng Wang,Gang Liu

DOI: https://doi.org/10.1016/j.intimp.2023.110708

Abstract:Background and aims: Non-alcoholic fatty liver disease (NAFLD) has become a significant cause of chronic liver disease in developed countries, as a result of the worldwide trend of obesity and associated metabolic syndrome. Obesity and high-fat diet (HFD) are very common in patients with NAFLD. However, how to screen out key differentially expressed genes (DEGs) is a challenging task. The purpose of this study is to study the screen of key genes and pathways of HFD on the formation process of non-alcoholic fatty liver through network pharmacological analysis. Methods: In this study, 173 genes associated with NAFLD were collected from the Gene Expression Omnibus (GEO) database. To find significant genes and pathways, combine network clustering analysis, topology analysis, and pathway analysis. Results: The results showed that there were four key signaling pathways related to HFD, including complement cascade, Atorvastatin ADME, Asthma and Aflatoxin activation and detoxification. In addition, we identified six representative key genes, including Ccl5, Tlr2, Cd274, Cxcl10, Cxcl9 and Cd74, and screened three intersecting genes in Mus musculus and Homo sapiens sample, including C3, F2 and C7. Conclusions: In conclusion, our study constructed the NAFLD gene regulatory network of C57BL/6J mice for the first time and jointly analyzed the Mus musculus samples and Homo sapiens samples. It provides new insights for identifying potential biomarkers and valuable therapeutic clues, and puts forward a new method for web-based research. These findings may provide potential targets for early diagnosis, effective therapy and prognostic markers of NAFLD.

Surgical Treatment of Chronic Amebic Colitis

LncRNA and circRNA in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review

The use of the microagglutination technique to determine the antibody status of healthy New Zealanders to Brucella abortus

An outcome audit at the epilepsy clinic: results from 1000 consecutive referrals

Identification of potential feature genes in non-alcoholic fatty liver disease using bioinformatics analysis and machine learning strategies

Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease

Recent Progress of Proteomics in Nonalcoholic Fatty Liver Disease*

Single-cell sequencing and multiple machine learning algorithms to identify key T-cell differentiation gene for progression of NAFLD cirrhosis to hepatocellular carcinoma

MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease.

Identification of Shared and Unique Key Biomarkers of Alcohol Liver Cirrhosis and Non-Alcoholic Steatohepatitis Through Machine Learning Network-Based Algorithms

An novel effective and safe model for the diagnosis of nonalcoholic fatty liver disease in China: gene excavations, clinical validations, and mechanism elucidation

Intelligent Diagnosis of Non-alcoholic Fatty Liver Disease Based on Multi-modal Ultrasound Features

Potential diagnostic markers shared between non-alcoholic fatty liver disease and atherosclerosis determined by machine learning and bioinformatic analysis

1567-P: Integrating Bioinformatics and Machine Learning to Identify Lactylation-Related Diagnostic Biomarkers and Characterize Immune Cell Infiltration in Nonalcoholic Fatty Liver Disease

Identification of key target genes and pathway analysis in nonalcoholic fatty liver disease via integrated bioinformatics analysis

Six-gene prognostic signature for non-alcoholic fatty liver disease susceptibility using machine learning

Gold neuropathy

Machine learning approaches for early detection of non-alcoholic steatohepatitis based on clinical and blood parameters

Identification of autophagy-related signatures in nonalcoholic fatty liver disease and correlation with non-parenchymal cells of the liver

Identification of neutrophil extracellular trap-related biomarkers in non-alcoholic fatty liver disease through machine learning and single-cell analysis

Combined with multiplex and network analysis to reveal the key genes and mechanisms of nonalcoholic fatty liver disease